Loading
Latest filing published 07 Sept 2023 for MARIZYME, INC., €8,907.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Braeden Lichti in Marizyme, Inc. Between 29 June 2023 and 29 August 2023, the trades on record add up to 6 filings.
In open-market terms, that means 3 purchases worth €34k on one side and 3 sales worth €34k on the other. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €8,907.
Most recently, on 8 September 2023, the filings show an open-market sale worth €8,907 in Marizyme, Inc. The last purchase on record was published on 7 September 2023, which is 1,143 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations